美国生物医药产业人才供给经验及启示

Experiences and Insights from the Talent Supply in the US Biopharmaceutical Industry

美国是当今世界生物医药的头号强国,其强大的创新能力离不开人才队伍的支撑,考察其人才供给经验,发现四个值得关注的方面:一是学科专业规模、结构、布局与产业需求同步协调发展,二是对全球范围优质生源的吸引力度超越了政策及疫情局限,三是相关专业管理机构、企业、研究机构积极参与人才培养,四是通过教育或资助方案延伸与拓展人才培养链条。借鉴美国的经验,建议我国试点放开先导产业领域相关学科专业设置及招生自主权,推动科研机构与企业助力后备人才的前沿知识储备与技能提升,推动大中小一体化培养STEM人才。

The United States stands as the world’s leading powerhouse in biopharmaceuticals,with its formidable innovation capabilities underpinned by a robust talent team.By examining its experiences,four noteworthy aspects are found:first,the scale,structure,and layout of academic disciplines align and evolve in harmony with industry demands;second,the attraction of top global talent surpasses the constraints of policies and pandemic limitations;third,active engagement from relevant government agencies,industries,and research institutions in talent cultivation is evident;fourth,education and funding schemes extend and broaden the talent cultivation pipeline.Drawing from the U.S.experience,it is recommended that China pilot initiatives to grant the autonomy of related academic discipline establishment and student admission in pioneering industries,facilitate the involvement of research institutions and enterprises in fostering the next generation of talents with cutting-edge knowledge and skills,and promote the integrated STEM talent cultivation ecosystem spanning primary,secondary,and higher education.